Supplemental and Alternative Crops (SAC) Competitive Grants Program
National Institute of Food and Agriculture (NIFA)
United States Department of Agriculture (USDA)
Deadline: 30 Mar 2021
Amount: see record
Center for Regulatory Excellence Grant
National Council of State Boards of Nursing (NCSBN)
Deadline: 2 Apr 2021
Amount: $300,000
Developing the Therapeutic Potential of the Endocannabinoid System for Pain Treatment (R01 - Clinical Trial Optional)
United States Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
Deadline: 7 May 2021 (AIDS and AIDS-related applications)
Amount: See Record
Advocacy Grants Program: Promoting Policy Change Grants
Drug Policy Alliance
Deadline: 15 May 2021 (LOI)
Amount: $50,000
Developing the Therapeutic Potential of the Endocannabinoid System for Pain Treatment (R01 - Clinical Trial Optional)
United States Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
Deadline: 5 June 2021 (new applications)
Amount: See Record
Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional)
United States Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute on Drug Abuse (NIDA)
Deadline: 8 June 2021
Amount: $275,000
Developing the Therapeutic Potential of the Endocannabinoid System for Pain Treatment (R01 - Clinical Trial Optional)
United States Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
Deadline: 5 July 2021 (renewals; resubmissions)
Amount: See Record
NIDA Translational Avant-Garde Award for Development of Medication to Treat Substance Use Disorders (UG3/UH3 Clinical Trial Optional)
National Institutes of Health (NIH)
United States Department of Health and Human Services (HHS)
Deadline: 26 July 2021 (New, resubmission, revision, AIDS and AIDS-related applications)
Amount: $1,000,000
Developing the Therapeutic Potential of the Endocannabinoid System for Pain Treatment (R01 - Clinical Trial Optional)
United States Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
Deadline: 7 Sept 2021 (AIDS and AIDS-related applications)
Amount: See Record
Request for Blepharospasm/Meige Research Proposals
Benign Essential Blepharospasm Research Foundation, Inc. (BEBRF)
Deadline: 30 Sep 2021
Amount: $100,000
Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional)
United States Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute on Drug Abuse (NIDA)
Deadline: 8 Oct 2021
Amount: $275,000
Farmer Rancher Grant Program
United States Department of Agriculture (USDA)
National Institute of Food and Agriculture (NIFA)
Sustainable Agriculture Research and Education (SARE)
Deadline: 3 Dec 2021
Amount: $27,000
Notice of Special Interest (NOSI): Public Health Research on Cannabis
United States Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute on Drug Abuse (NIDA)
Deadline: 7 Jan 2022
Amount: See Record
Public Health Research on Cannabis
National Institute on Drug Abuse (NIDA)
Deadline: 8 Jan 2022
Amount: See Record
Policy Rapid Response Research Award
Tobacco-Related Disease Research Program of California (TRDRP)
Deadline: 5 Mar 2022
Amount: $200,000
Canine Grants
Morris Animal Foundation (MAF)
Deadline: 10 Mar 2022
Amount: $100,000
NIDA Translational Avant-Garde Award for Development of Medication to Treat Substance Use Disorders (UG3/UH3 Clinical Trial Optional)
National Institutes of Health (NIH)
United States Department of Health and Human Services (HHS)
Deadline: 25 July 2022 (New, resubmission, revision, AIDS and AIDS-related applications)
Amount: $1,000,000
NIDA Translational Avant-Garde Award for Development of Medication to Treat Substance Use Disorders (UG3/UH3 Clinical Trial Optional)
National Institutes of Health (NIH)
United States Department of Health and Human Services (HHS)
Deadline: 25 July 2023 (New, resubmission, revision, AIDS and AIDS-related applications)
Amount: $1,000,000
Notice of Special Interest (NOSI): Cannabis, Prescription Opioid, or Prescription Benzodiazepine Drug Use Among Older Adults
United States Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute on Drug Abuse (NIDA)
Deadline: 7 Sep 2023
Amount: See Record
Notice of Special Interest (NOSI): Effects of Cannabis Use and Cannabinoids on the Developing Brain
United States Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute on Drug Abuse (NIDA)
Deadline: 7 Sep 2023
Amount: See Record
Notice of Special Interest (NOSI): Research Training and Career Development Awards to Support Individuals Pursuing Research Focused on Developing Treatments for Substance Use Disorders and the Associated Medical Consequences of these Disorders
United States Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute on Drug Abuse (NIDA)
Deadline: 7 Sep 2023
Amount: See Record
Notice of Special Interest (NOSI): Effects of smoking and vaping on the risk and outcome of COVID-19 infection
United States Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute on Drug Abuse (NIDA)
Deadline: 7 Sep 2024
Amount: See Record
Notice of Special Interest (NOSI): Medical Consequences of Smoking and Vaping Drugs of Abuse in Individuals with HIV and COVID-19
United States Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
Deadline: 7 Sep 2024
Amount: See Record